These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26621642)

  • 21. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Ackerman MJ; Zipes DP; Kovacs RJ; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2424-2428. PubMed ID: 26542662
    [No Abstract]   [Full Text] [Related]  

  • 22. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE
    J Am Coll Cardiol; 2015 Dec; 66(21):2385-2392. PubMed ID: 26542667
    [No Abstract]   [Full Text] [Related]  

  • 23. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NAM; Cooper LT; Link MS; Maron MS
    J Am Coll Cardiol; 2015 Dec; 66(21):2362-2371. PubMed ID: 26542657
    [No Abstract]   [Full Text] [Related]  

  • 24. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Black HR; Sica D; Ferdinand K; White WB
    J Am Coll Cardiol; 2015 Dec; 66(21):2393-2397. PubMed ID: 26542658
    [No Abstract]   [Full Text] [Related]  

  • 25. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Link MS; Estes NAM; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2439-2443. PubMed ID: 26542669
    [No Abstract]   [Full Text] [Related]  

  • 26. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Van Hare GF; Ackerman MJ; Evangelista JA; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL;
    Circulation; 2015 Dec; 132(22):e281-91. PubMed ID: 26621645
    [No Abstract]   [Full Text] [Related]  

  • 27. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Zipes DP; Link MS; Ackerman MJ; Kovacs RJ; Myerburg RJ; Estes NAM
    J Am Coll Cardiol; 2015 Dec; 66(21):2412-2423. PubMed ID: 26542670
    [No Abstract]   [Full Text] [Related]  

  • 28. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Van Hare GF; Ackerman MJ; Evangelista JK; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL
    J Am Coll Cardiol; 2015 Dec; 66(21):2372-2384. PubMed ID: 26542660
    [No Abstract]   [Full Text] [Related]  

  • 29. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Estes NAM; Kovacs RJ; Baggish AL; Myerburg RJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2429-2433. PubMed ID: 26542661
    [No Abstract]   [Full Text] [Related]  

  • 30. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Link MS; Myerburg RJ; Estes NAM
    J Am Coll Cardiol; 2015 Dec; 66(21):2434-2438. PubMed ID: 26542665
    [No Abstract]   [Full Text] [Related]  

  • 31. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH
    J Am Coll Cardiol; 2015 Dec; 66(21):2350-2355. PubMed ID: 26542656
    [No Abstract]   [Full Text] [Related]  

  • 32. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Braverman AC; Harris KM; Kovacs RJ; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2398-2405. PubMed ID: 26542664
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
    ; ; ; ; Wann LS; Curtis AB; Ellenbogen KA; Estes NA; Ezekowitz MD; Jackman WM; January CT; Lowe JE; Page RL; Slotwiner DJ; Stevenson WG; Tracy CM; Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Le Heuzey J; Kay GN; Lowe JE; Olsson SB; Prystowsky EN; Tamargo JL; Wann LS
    Circulation; 2013 May; 127(18):1916-26. PubMed ID: 23545139
    [No Abstract]   [Full Text] [Related]  

  • 34. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected].
    Tracy CM; Epstein AE; Darbar D; DiMarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD; Ellenbogen KA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hayes DL; Page RL; Stevenson LW; Sweeney MO; ; ;
    Circulation; 2012 Oct; 126(14):1784-800. PubMed ID: 22965336
    [No Abstract]   [Full Text] [Related]  

  • 35. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
    Anderson JL; Heidenreich PA; Barnett PG; Creager MA; Fonarow GC; Gibbons RJ; Halperin JL; Hlatky MA; Jacobs AK; Mark DB; Masoudi FA; Peterson ED; Shaw LJ
    J Am Coll Cardiol; 2014 Jun; 63(21):2304-22. PubMed ID: 24681044
    [No Abstract]   [Full Text] [Related]  

  • 36. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
    Yancy CW; Jessup M; Bozkurt B; Butler J; Casey DE; Drazner MH; Fonarow GC; Geraci SA; Horwich T; Januzzi JL; Johnson MR; Kasper EK; Levy WC; Masoudi FA; McBride PE; McMurray JJ; Mitchell JE; Peterson PN; Riegel B; Sam F; Stevenson LW; Tang WH; Tsai EJ; Wilkoff BL
    Circulation; 2013 Oct; 128(16):1810-52. PubMed ID: 23741057
    [No Abstract]   [Full Text] [Related]  

  • 37. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Jacobs AK; Anderson JL; Halperin JL
    J Am Coll Cardiol; 2014 Sep; 64(13):1373-84. PubMed ID: 25103073
    [No Abstract]   [Full Text] [Related]  

  • 38. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.
    Goldberger JJ; Cain ME; Hohnloser SH; Kadish AH; Knight BP; Lauer MS; Maron BJ; Page RL; Passman RS; Siscovick D; Siscovick D; Stevenson WG; Zipes DP; ; ;
    Circulation; 2008 Sep; 118(14):1497-1518. PubMed ID: 18833586
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Guyton RA; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK
    Circulation; 2013 Apr; 127(13):1425-43. PubMed ID: 23457117
    [No Abstract]   [Full Text] [Related]  

  • 40. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Al-Khatib SM; Stevenson WG; Ackerman MJ; Bryant WJ; Callans DJ; Curtis AB; Deal BJ; Dickfeld T; Field ME; Fonarow GC; Gillis AM; Granger CB; Hammill SC; Hlatky MA; Joglar JA; Kay GN; Matlock DD; Myerburg RJ; Page RL
    Heart Rhythm; 2018 Oct; 15(10):e73-e189. PubMed ID: 29097319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.